Sejaro and Semavik Next won the 2026 Product of the Year award for the first time
On November 12, 2026, the ceremony of the 28th national award “Product of the Year 2026” was held in the Connect space in Moscow

On November 12, 2026, the ceremony of the 28th national award “Product of the Year 2026” was held in the Connect space in Moscow. GEROPHARM became a laureate in two nominations of the category “Medical preparations and health products”.
The award in the category “Consumer confidence” received the drug “Semavik Next”, writes newstula.ru. According to RNC Pharma, for eight months of 2026, the Semavik brand occupied more than half of the Russian market of the corresponding molecule in physical terms, and the Semavik Next line reached the first place in sales in the category.
In the nomination “Innovation” the award was received by “Sejaro”. This is a tyrzepatide-based tool with a digital service: the Stroynee app structures the patient’s work by combining drug data, training materials and an injection diary. According to DSM Group, for the first seven months of 2026, the brand showed the maximum growth rate among Russian pharmacy brands.
The category for the first time noted drugs for weight correction. The award is based on the national rating (more than 60 categories) and is awarded with the support of the National Trade Association. General Director of the company Peter Rodionov noted that such a result is the merit of the entire team and the trust of patients. He added that the company will continue to work on the availability of drugs and ease of use.

